Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02393534 · ClinicalTrials.gov registry record · Phase 4

Feasibility of Telephone Follow-up Visits in Primary Care

A Phase 4 study of No Specific Condition, sponsored by NYU Langone Health.

Completed
Registry status
Phase 4
Development phase
11
Enrollment target
1
Study location

NCT02393534 is a Phase 4 study of No Specific Condition that has completed, run by NYU Langone Health. The registered enrollment target is 11 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02393534, a Phase 4 study of No Specific Condition, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
Phase 4
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

Doctors frequently speak with their patients over the telephone. Having a visit with a doctor over the telephone rather than face-to-face can be convenient for patients and allow them to save time and money on transportation and missed time from work. However, some patients may prefer seeing the doctor in person. In this study, we will study two groups of patients - some who have their visits with their doctor over the telephone and some who have them face-to-face. Using surveys and interviews, we will study if the groups differ in their satisfaction with their visit with their doctor after participating in the study for 6 months. We will also look at doctor satisfaction with telephone visits, use of clinic resources and if patients received recommended care such as laboratory tests and vaccines during the study period.

Conditions Studied

Interventions

  • OTHER Telephone Visit

Study Locations (1)

New York

  • Gouverneur TDC - New York

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2015-06
Est. Completion 2016-04
Phase Phase 4

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02393534

The ClinicalTrials.gov registry entry for NCT02393534 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with No Specific Condition appearing as the primary indexed condition, and to 1 intervention - of which Telephone Visit is the first listed.

NCT02393534 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02393534 about?

NCT02393534 is a clinical study titled "Feasibility of Telephone Follow-up Visits in Primary Care". Doctors frequently speak with their patients over the telephone. Having a visit with a doctor over the telephone rather than face-to-face can be convenient for patients and allow them to save time and money on transportation and missed time from work. However, some patients may prefer seeing the doc...

What is the current status of trial NCT02393534?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2015-06. Estimated completion is 2016-04.

What conditions does trial NCT02393534 study?

This clinical trial studies the following conditions: No Specific Condition.

What interventions are being tested in trial NCT02393534?

The interventions under investigation include: Telephone Visit (OTHER).

Who is sponsoring clinical trial NCT02393534?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02393534 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.